Shuimu Biosciences

PharmaceuticalsAngelBeijing, Chinashuimubio.com

Latest round

Angel

Last raised

Aug 2024

Total raised

$14M

Investors

10

About Shuimu Biosciences

Established in 2017 and based in Beijing, China, Shuimu Biosciences Ltd. is a healthcare company that focuses on new drug development. The company's CEO Mr.com. The company provides services of Transmission Electron Microscopy, coupled with single particle analysis (Cryo-EM), Microcrystal electron diffraction (Micro-ED), X-ray crystallography, Negative Staining, and Protein Production and Purification. Cryo-EM has become a standard structural technique for the structural determination of proteins and protein complexes. It is a technique to map the interactions between antibodies and antigens and has many applications in antibody development and biologics discovery.

Who invested in Shuimu Biosciences

10 investors across 3 rounds

See all investors in Shuimu Biosciences

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Angel

    Aug 14, 2024

    Amount

    $14M

    Investors

    Locked

  2. Series A

    Sep 8, 2021

    Amount

    Undisclosed

    Investors

    Locked

  3. Angel

    Mar 7, 2020

    Amount

    Undisclosed

    Investors

    Locked

Questions about Shuimu Biosciences

Who invested in Shuimu Biosciences?

Shuimu Biosciences has 10 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Shuimu Biosciences raised?

Shuimu Biosciences has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did Shuimu Biosciences last raise money?

Shuimu Biosciences's most recent round on record is a Angel, in Aug 2024.

What does Shuimu Biosciences do?

Established in 2017 and based in Beijing, China, Shuimu Biosciences Ltd.

Where is Shuimu Biosciences headquartered?

Shuimu Biosciences is headquartered in Beijing, China.

Which VCs invest in companies like Shuimu Biosciences?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back pharmaceuticals companies at Shuimu Biosciences's stage. Their profiles are linked below.

Raising like Shuimu Biosciences? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.